Bicocca Open Archive

Logo unimib boa
CORTESI, PAOLO ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.640
EU - Europa 5.931
AS - Asia 2.724
SA - Sud America 153
AF - Africa 37
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 12
Totale 19.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.446
IT - Italia 1.566
DE - Germania 902
SG - Singapore 891
CN - Cina 799
IE - Irlanda 667
SE - Svezia 645
RU - Federazione Russa 610
HK - Hong Kong 508
UA - Ucraina 357
GB - Regno Unito 292
FR - Francia 242
CA - Canada 176
FI - Finlandia 154
ID - Indonesia 148
DK - Danimarca 146
BR - Brasile 126
AT - Austria 114
IN - India 91
TR - Turchia 82
VN - Vietnam 76
NL - Olanda 64
BE - Belgio 43
CH - Svizzera 28
IR - Iran 26
ES - Italia 20
AU - Australia 19
CZ - Repubblica Ceca 19
KR - Corea 19
PH - Filippine 12
BG - Bulgaria 11
EU - Europa 11
MX - Messico 11
PK - Pakistan 11
RO - Romania 11
JP - Giappone 9
NO - Norvegia 8
AR - Argentina 7
CL - Cile 7
PT - Portogallo 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BD - Bangladesh 5
ET - Etiopia 5
GR - Grecia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
PL - Polonia 5
TH - Thailandia 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AL - Albania 4
EC - Ecuador 4
GH - Ghana 4
IQ - Iraq 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
VE - Venezuela 4
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
LK - Sri Lanka 3
LT - Lituania 3
SC - Seychelles 3
BZ - Belize 2
EG - Egitto 2
IL - Israele 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
SO - Somalia 2
A1 - Anonimo 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VG - Isole Vergini Britanniche 1
Totale 19.521
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.847
Fairfield 858
Woodbridge 832
Chandler 727
Singapore 724
Houston 662
Dublin 642
Frankfurt am Main 582
Wilmington 559
Ashburn 551
Hong Kong 498
Milan 448
Santa Clara 385
Jacksonville 380
Seattle 374
Dearborn 345
New York 331
Cambridge 280
Princeton 278
Nanjing 144
Jakarta 138
Altamura 128
Lawrence 124
Vienna 95
Shanghai 86
Helsinki 63
San Diego 62
Lachine 60
Beijing 58
Rome 55
London 52
Andover 51
Nanchang 47
Guangzhou 44
Dong Ket 43
Toronto 41
Nuremberg 40
Shenyang 40
Boardman 39
Tianjin 36
Ottawa 34
Brussels 33
Fremont 33
Hebei 28
Jiaxing 28
Jinan 27
Lissone 27
Falls Church 25
Los Angeles 25
Munich 25
Zhengzhou 25
Lappeenranta 24
Redmond 24
Bologna 23
Changsha 23
Hangzhou 22
Verona 22
Ningbo 21
Paris 20
Pune 20
Washington 20
Chicago 17
Kocaeli 17
San Jose 17
Kunming 16
Mountain View 16
Norwalk 16
Parma 15
Boston 14
Legnano 13
Taizhou 13
Florence 12
Hefei 12
Monza 12
Bergamo 11
Palermo 11
Perugia 11
São Paulo 11
Bonndorf 10
Carate Brianza 10
Edmonton 10
Naples 10
Nürnberg 10
San Mateo 10
Dallas 9
Huizen 9
Montréal 9
Padova 9
Brno 8
Madrid 8
Pavia 8
Phoenix 8
Prague 8
Tappahannock 8
Turin 8
Brescia 7
Buffalo 7
Central 7
Indianapolis 7
San Francisco 7
Totale 13.699
Salva come PNG Salva come JPEG
Nome #
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 344
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 338
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors 298
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 298
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review 279
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 243
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 225
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 223
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 199
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 196
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 196
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 195
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 193
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 192
Health Related Quality of Life in the Major Liver Conditions 190
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 186
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 184
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 184
Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 184
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 182
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 182
Health related quality of life in chronic liver diseases 182
The impact of liver disease on the health-related quality of life 179
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 177
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 176
Sustainability of the Italian National Health Service 176
Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017 176
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 174
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 174
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 174
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 173
Economic Burden of Urticaria Requiring Hospitalization: Analysis from an Administrative Database 172
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 171
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 171
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 171
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 170
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 169
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 169
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 168
Costs and effectiveness of influenza vaccination: A systematic review 166
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 166
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 165
The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis: A Population-Based Study 164
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 161
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 160
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 158
The socioeconomic burden of patients affected by hemophilia with inhibitors 158
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 157
Economic Burden Of Stroke: Analysis From An Administrative Database 156
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 155
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 154
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 153
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 152
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 152
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 149
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 147
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 147
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 146
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 145
Epidemiology and Direct Health Care Costs of Diabetic Retinopathy: Results From a Population-Based Study 141
Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A 139
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 137
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 137
Use of health care administrative databases to estimate the burden of breast cancer. 135
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 135
Epidemiologic And Economic Burden Attributable To Atrial Fibrillation From Administrative Data 134
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 134
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) 134
Italian population-based values of EQ-5D health states 133
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 133
Use of health care administrative databases to estimate incidence of foot complications in diabetes patients 130
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 130
Preferenze della popolazione italiana per gli stati di salute dell'EQ-5D 129
Utilization of antispasticity drugs in multiple sclerosis: analysis from an Italian administrative database 128
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study 128
Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery: Analysis from an Italian Administrative Database 125
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 125
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 124
Health economic models in hemophilia A and utility assumptions from a clinician's perspective 123
Use of healthcare administrative databases to estimate the burden of diabaetes mellitus: a population-based study 123
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: Results from Italy 122
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 121
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 120
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases 120
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era 118
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 117
Utilization of disease modifying agents in multiple sclerosis: analysis from an Italian administrative database. 114
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 114
Patients’ and physicians’ needs, experiences and preferences in the treatment of rght ventricular outflow tract dysfunction. 113
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 113
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation 112
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 111
Difference in health related quality of life of chronic liver diseases and general population 110
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 110
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 110
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 109
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry 108
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 107
Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy 107
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study 105
Totale 15.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.088 0 0 0 0 0 0 0 296 330 212 206 44
2020/20212.589 178 117 297 239 258 182 230 239 202 231 148 268
2021/20221.868 137 182 253 178 130 146 64 121 109 129 106 313
2022/20233.149 327 896 275 271 212 452 57 195 222 49 100 93
2023/20242.714 98 119 93 149 295 645 397 119 233 114 146 306
2024/20253.386 352 716 355 366 610 469 444 74 0 0 0 0
Totale 20.637